• Mashup Score: 6
    MSK Research Highlights July 17, 2023 - 1 year(s) ago

    New MSK research identified a way to reduce toxicity in CAR T cell therapy; discovered a division of labor in DNA repair that suggests a possible therapeutic strategy for certain cancers; developed a new method to enable imaging of two PET tracers simultaneously; found biomarkers that could help predict outcomes in HER2-positive metastatic esophagogastric cancer; and made progress toward…

    Source: Memorial Sloan Kettering Cancer Center
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of MSKCancerCenter
      MSKCancerCenter

      An MSK team led by @jaeparkmd found that giving a drug called anakinra patients undergoing #CARTcelltherapy reduced severe neurotoxicity from a rate of 28%–38% usually seen with standard anti-CD19 CAR T therapy to only 9.7%. Read more here: https://t.co/PyIGht61YW https://t.co/e7NA9WDEG8

  • Mashup Score: 3
    Tumor Metabolism Atlas Offers a New Way to Discover Cancer Mechanisms - 1 year(s) ago

    An atlas that catalogues gene activity and the levels of small molecules called metabolites in tumor samples offers a new way of identifying the deep mechanisms of cancer, according to researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center.

    Source: WCM Newsroom
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of MSKCancerCenter
      MSKCancerCenter

      An atlas that catalogues gene activity and the levels of small molecules called metabolites in tumor samples offers a new way of identifying the deep mechanisms of cancer, according to new research led by @EdReznik of MSK and @JanKrumsiek of @WeillCornell. https://t.co/Rpf7RvEyeo

  • Mashup Score: 3
    MSK Research Highlights, June 29, 2023 - 1 year(s) ago

    New MSK research discovered ferroptosis regulators that suggest therapeutic opportunities against hormone receptor-positive cancers; examined how tumor-associated macrophages might be turned against cancer; acquired new insights into joint inflammation in rheumatoid arthritis; developed a systems-level platform called epichaperomics to map changes in interactors among thousands of proteins…

    Source: Memorial Sloan Kettering Cancer Center
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of MSKCancerCenter
      MSKCancerCenter

      MSK researchers are making strides against #cancer every day. New research explored new opportunities against hormone receptor-positive cancers, how tumor-associated macrophages might be turned against cancer, and how AI could help diagnose breast cancer. https://t.co/lws4GfzdCU

  • Mashup Score: 4
    Exposing a Cancer Cell’s Weakness - 1 year(s) ago

    MSK has developed an arsenal of tests that are at the front lines of precision treatments. They target the structure of proteins that cause cancer, offering people new hope.

    Source: Memorial Sloan Kettering Cancer Center
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of MSKCancerCenter
      MSKCancerCenter

      How 2 MSK-developed #cancer #genetictests - MSK-IMPACT® (which uses a tissue biopsy to identify the best treatment) & MSK-ACCESS® (a blood test to detect a patient's response to treatment) - have helped revolutionize the way cancer is treated worldwide: https://t.co/V4ml1fDJe9 https://t.co/HVpsweiKCs

Load More